1-3 of 3
Michael Quigley
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B61: High-dimensional analysis of tumor-resident CD4 and CD8 double-negative T-cell subset in multiple tumor types

Murali Gururajan, Ravi Kandasamy, Jessica Wong, Kalpit Shah, Shuoguo Wang, Adam Bata, Amy Truong, Sunil Kuppasani, Ching-Ping Ho, Robert Graziano, Michael Quigley, Anwar Murtaza, Jinqi Liu
Journal: Cancer Immunology Research
Cancer Immunol Res (2020) 8 (4_Supplement): B61.
https://doi.org/10.1158/2326-6074.TUMIMM18-B61
Published: 01 April 2020
View article titled, Abstract B61: High-dimensional analysis of tumor-resident CD4 and CD8 double-negative T-cell subset in multiple tumor types
Journal Articles

Combination of CD40 Agonism and CSF-1R Blockade Reconditions Tumor-Associated Macrophages and Drives Potent Antitumor Immunity

Karla R. Wiehagen, Natasha M. Girgis, Douglas H. Yamada, Andressa A. Smith, Szeman Ruby Chan, Iqbal S. Grewal, Michael Quigley, Raluca I. Verona
Journal: Cancer Immunology Research
Series: Author Choice
Cancer Immunol Res (2017) 5 (12): 1109–1121.
https://doi.org/10.1158/2326-6066.CIR-17-0258
Published: 30 November 2017
View article titled, Combination of CD40 Agonism and CSF-1R Blockade Reconditions Tumor-Associated Macrophages and Drives Potent Antitumor Immunity
Open the PDF for Combination of CD40 Agonism and CSF-1R Blockade Reconditions Tumor-Associated Macrophages and Drives Potent Antitumor Immunity in another window
Includes: Supplementary data
Journal Articles

Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells

Mark J. Selby, John J. Engelhardt, Michael Quigley, Karla A. Henning, Timothy Chen, Mohan Srinivasan, Alan J. Korman
Journal: Cancer Immunology Research
Cancer Immunol Res (2013) 1 (1): 32–42.
https://doi.org/10.1158/2326-6066.CIR-13-0013
Published: 10 July 2013
View article titled, Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells
Open the PDF for Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells in another window
Includes: Supplementary data